Publishing research using ab28479? Please let us know so that we can cite the reference in this datasheet.

ab28479 has been referenced in 5 publications.

  • Mukwaya A  et al. Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization. Angiogenesis 21:395-413 (2018). WB, IHC-P ; Rat . PubMed: 29445990
  • Pan LL  et al. (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B. Front Pharmacol 9:195 (2018). PubMed: 29593532
  • Nikolova V  et al. Changes in LXR signaling influence early-pregnancy lipogenesis and protect against dysregulated fetoplacental lipid homeostasis. Am J Physiol Endocrinol Metab 313:E463-E472 (2017). PubMed: 28420650
  • Seto NL & Bogan RL Decreased cholesterol uptake and increased liver x receptor-mediated cholesterol efflux pathways during prostaglandin F2 alpha-induced and spontaneous luteolysis in sheep. Biol Reprod 92:128 (2015). WB ; Sheep . PubMed: 25882703
  • He Q  et al. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice. Cardiovasc Diabetol 13:149 (2014). Mouse . PubMed: 25416469

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up